Home/Filings/4/0001493152-22-036319
4//SEC Filing

Mohan Pankaj 4

Accession 0001493152-22-036319

CIK 0001106838other

Filed

Dec 21, 7:00 PM ET

Accepted

Dec 22, 4:31 PM ET

Size

6.8 KB

Accession

0001493152-22-036319

Insider Transaction Report

Form 4
Period: 2022-12-14
Mohan Pankaj
DirectorChairman, President and CEO
Transactions
  • Award

    Common Stock

    2022-12-14+74,205748,606 total
Holdings
  • Common Stock

    (indirect: By Children)
    7,992
  • Common Stock

    (indirect: By Mohan Family Office)
    930,705
Footnotes (3)
  • [F1]On December 14, 2022, the Reporting Person was granted 74,205 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on January 1, 2024.
  • [F2]Includes unvested RSUs.
  • [F3]Reporting Person jointly exercises dispositive and voting power over the securities owned by the Mohan Family Office.

Documents

1 file

Issuer

Sonnet BioTherapeutics Holdings, Inc.

CIK 0001106838

Entity typeother

Related Parties

1
  • filerCIK 0001664386

Filing Metadata

Form type
4
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 4:31 PM ET
Size
6.8 KB